All lobbying filings

CORMEDIX INC.

Lobbying for CORMEDIX INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $150,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

S 2730
Kidney Care Access Protection Act

Lobbying activity 1

Health Issues

S. 2730, Kidney Care Access Protection Act H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.